Answers are grounded in this paper and cite their sources.
Case report reveals effective management of livedoid vasculopathy via pentoxifylline and aspirin in a young woman, highlighting tailored care balancing hypercoagulability and pregnancy goals.
Livedoid vasculopathy (LV) is a rare, chronic vascular disorder marked by painful, recurrent ulcerations that primarily affect the lower extremities.It is frequently associated with hypercoagulable states, although its pathophysiology remains incompletely understood.We present the case of a 25-year-old woman with a longstanding history of LV, elevated factor VIII, increased lipoprotein(a), recurrent kidney stones, and iron deficiency anemia who presented with worsening lower-extremity ulcerations.An extensive workup excluded other hypercoagulable and connective-tissue conditions, leaving elevated factor VIII and lipoprotein(a) as the most likely contributors to her disease.Although her symptoms initially resolved with treatment, they recurred over time, and management was further complicated by her desire for future pregnancy, which precluded the use of several standard anticoagulant therapies.Her regimen was ultimately centered on pentoxifylline and low-dose aspirin to control symptoms while minimizing risk to a future pregnancy.This case illustrates the importance of individualized treatment planning in LV, particularly when hypercoagulable risk factors intersect with reproductive goals.
No takes yet. Share an insight, caveat, or question.
Nudelman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: